A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine.
The long delays some COVID patients experience in regaining consciousness after ventilation may protect the brain from oxygen deprivation, new research shows.
MBA candidates in the first cohort of Cornell's new BioEntrepreneurship Initiative will collaborate with doctoral researchers in the life sciences across Cornell. The program is designed to develop startup leaders and foster innovation in the life sciences.
Halomine and Inso Biosciences – both from Cornell incubators – have received $3 million in New York state grants to help thwart disease outbreaks and expand the state’s life science industries.
A Cornell team has developed a way to spatially map the entire spectrum of RNA in a cell’s transcriptome, revealing the role of previously elusive RNA in skeletal muscle regeneration and viral myocarditis in mice.
The new approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range of diseases.
Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.
A portable diagnostic device designed by researchers at Cornell Engineering and Weill Cornell Medicine seeks to provide a fast and accurate diagnosis of Kaposi sarcoma, a common yet difficult-to-detect cancer that often signals the presence of HIV infection.
The upgrades reflect Martha Van Rensselaer’s original philosophy for the College of Human Ecology, and the innovative, multidisciplinary institution it has evolved into over time.